N-PORT filing recap · April 2021

What did ARK Genomic Revolution ETF buy in April 2021?

Reported stock-position changes between this filing and the previous one. These are ARK Genomic Revolution ETF's own holdings, not the firm's.

Stock value

$9.62B

Positions

Estimated turnover

23.5%

Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.

New positions

BFLYButterfly Network, Inc.$95.02Mreported value+6.56M shares ABBVAbbvie Inc.$62.28Mreported value+558.6K shares SGFYSignify Health Inc$58.97Mreported value+2.08M shares CMLFCm Life Sciences Inc$58.41Mreported value+4.31M shares SEERSeer, Inc.$43.71Mreported value+858.3K shares PATHUipath, Inc.$43.71Mreported value+607.0K shares RXRXRecursion Pharmaceuticals, Inc.$43.14Mreported value+1.29M shares ZYZymergen Inc.$20.51Mreported value+442.2K shares CMIIUCm Life Sciences II Inc$2.61Mreported value+192.4K shares

Increased positions

TDOCTeladoc Health, Inc.$693.65Mreported value+786.0K shares+24.3%EXASExact Sciences Corporation$489.86Mreported value+604.0K shares+19.4%REGNRegeneron Pharmaceuticals, Inc.$437.25Mreported value+95.4K shares+11.7%VRTXVertex Pharmaceuticals Inc / Ma$378.54Mreported value

Reduced positions

PACBPacific Biosciences of California, Inc.$413.39Mreported value-4.05M shares-22.6%TWSTTwist Bioscience Corporation$394.20Mreported value-715.0K shares-19.6%CDNACaredx, Inc.$356.02Mreported value-663.7K shares-12.8%RHHBYRoche Holding AG$317.70Mreported value-1.27M shares

Exited positions

GOOGLAlphabet Inc.$146.67Mprior reported value-80.3K shares-100.0%LGVWLongview Acquisition Corp.$35.40Mprior reported value-1.92M shares-100.0%HIMSHims & Hers Health, Inc.$8.74Mprior reported value-460.1K shares-100.0%